BioTarget is a global biotech competition aimed at identifying and supporting those working on new molecules for cancer therapy. Research groups with entrepreneurial ambitions and young biotech companies can submit a proposal by March 29th. The shortlisted candidates will be invited for a pitch event in London, UK, and the three winners will receive free experimentation worth up to $100,000 in Europe’s leading robotic cloud lab to reach their next milestone.
One in two people will be diagnosed with cancer during their lifetime. BioTarget is the world’s first biotech competition for emerging companies dedicated to finding new molecules for cancer treatment.
The competition invites applications from early ventures seeking to characterise further or validate their drug targets using cellular and molecular assays. Following the online application, the top 10 applicants will be invited to attend the pitch event in London, where they will present their projects in front of an expert panel and a diverse audience consisting of life science investors, industry professionals, academics, and fellow entrepreneurs.
Win free experimentation worth up to $100,000 conducted in Arctoris’ cloud lab equal to one year of lab work.
In addition to free experimentation, the three winners will benefit from the BioTarget partners’ business support. This means free IP training, hands-on business mentoring from experienced entrepreneurs and executives, and access to a leading network of bio-entrepreneurs and investors.
1st prize: free experiments worth $100k
2nd prize: free experiments worth $50k
3rd prize: free experiments worth $20k
Publicity & Network
Get your company promoted to an exclusive audience through all Science Entrepreneur Club channels (article, interview and more).
Become part of a unique network and get the opportunity to connect to investors, industry professionals and fellow entrepreneurs.